Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.

Philip, George; Villarán, Cesar; Pearlman, David S; Loeys, Tom; Dass, S Balachandra; Reiss, Theodore F

Philip, George; Villarán, Cesar; Pearlman, David S; Loeys, Tom; Dass, S Balachandra; Reiss, Theodore F.

Affiliation

Philip G; Merck Research Laboratories. Rahway, NJ 07065, USA. george.philip@merck.com

J Asthma ; 44(3): 213-7, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17454341

Subject(s)

Acetates/administration & dosage; Asthma, Exercise-Induced/drug therapy; Asthma, Exercise-Induced/physiopathology; Bronchoconstriction/drug effects; Exercise; Leukotriene Antagonists/administration & dosage; Quinolines/administration & dosage; Acetates/adverse effects; Acetates/therapeutic use; Administration, Oral; Adolescent; Adult; Cross-Over Studies; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists/adverse effects; Leukotriene Antagonists/therapeutic use; Male; Quinolines/adverse effects; Quinolines/therapeutic use; Sulfides; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Asthma, Exercise-Induced / Exercise / Bronchoconstriction / Leukotriene Antagonists / Acetates Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Asthma Year: 2007 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links